Tumor infiltrating CD8 T cells and CAR-T cells express inhibitory checkpoints, such as PD-1 and CTLA-4, which can suppress T cell activity upon binding their ligand expressed on cancer cells and tumor-infiltrating myeloid cells [47]. Here, CTLA4 is linked to neoplasm.